Gensight Biologics SA Net Asset Quality Index
Gensight Biologics SA net asset quality index. Gensight Biologics SA (SIGHT) has a Net Asset Quality Index of -302.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €8.26 Million minus total liabilities of €33.20 Million yields net assets of €-24.94 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Gensight Biologics SA (SIGHT) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Gensight Biologics SA (2012–2025)
Net asset quality index of Gensight Biologics SA from 2012 to 2025. This chart shows how Gensight Biologics SA's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the index stands at -302.1%, representing net assets of €-24.94 Million against total assets of €8.26 Million EUR. Check SIGHT capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Gensight Biologics SA Net Asset Quality Index by Year (2012–2025)
Gensight Biologics SA net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Gensight Biologics SA from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Gensight Biologics SA (SIGHT) market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -302.1% | €-24.94 Million | €8.26 Million | €33.20 Million | ▼ -51.8 pp |
| 2024 | -250.3% | €-26.92 Million | €10.76 Million | €37.68 Million | ▲ +85.9 pp |
| 2023 | -336.2% | €-30.70 Million | €9.13 Million | €39.83 Million | ▼ -277.3 pp |
| 2022 | -58.9% | €-15.28 Million | €25.94 Million | €41.22 Million | ▼ -87.1 pp |
| 2021 | 28.2% | €15.99 Million | €56.65 Million | €40.66 Million | ▲ +3.6 pp |
| 2020 | 24.6% | €11.67 Million | €47.36 Million | €35.69 Million | ▼ -11.5 pp |
| 2019 | 36.2% | €11.75 Million | €32.48 Million | €20.74 Million | ▼ -28.4 pp |
| 2018 | 64.6% | €23.87 Million | €36.98 Million | €13.11 Million | ▼ -23.9 pp |
| 2017 | 88.4% | €55.00 Million | €62.21 Million | €7.22 Million | ▼ -1.7 pp |
| 2016 | 90.1% | €53.34 Million | €59.23 Million | €5.89 Million | ▲ +9.3 pp |
| 2015 | 80.8% | €29.33 Million | €36.31 Million | €6.98 Million | ▲ +9.4 pp |
| 2014 | 71.4% | €10.58 Million | €14.82 Million | €4.24 Million | ▼ -18.5 pp |
| 2013 | 89.9% | €16.97 Million | €18.87 Million | €1.91 Million | ▲ +199.6 pp |
| 2012 | -109.7% | €-66.47K | €60.62K | €127.08K | — |